Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Net income: CA$2.60m (up 40% from 2Q 2024). Profit margin: 3.2% (up from 2.9% in 2Q 2024). EPS: CA$0.05 (up from CA$0.048 in ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Shares of Aurora Cannabis Inc. ACB slid 1.05% to $4.73 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Q2 2025 Earnings Call Transcript November 6, 2024 Operator: Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only ...

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

Roth MKM analyst William Kirk reiterated a Hold rating on Aurora Cannabis (ACB – Research Report) today and set a price target of C$8.00. The company’s shares opened today at $5.14. Kirk covers the ...

Greetings, and welcome to the Aurora Cannabis Inc. second quarter 2025 results conference call. [Operator instructions] This conference call is being recorded today, Wednesday, November 6 ...

Working capital for the three months ended September 30, 2023 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A. View ...

Canopy Growth (CGC) shares plunged more than 20%, Aurora Cannabis (ACB) dropped 18%, and Tilray Brands (TRLY) lost over 13% intraday Wednesday. Adult-use marijuana is legal in 24 U.S. states and ...

Cannabis delivery has been legal in Colorado for a few years now, with a handful of cars or vans driving around Denver and ...